Bose-Einstein condensation of non-ground-state caesium atoms.

Bose-Einstein condensates of ultracold atoms serve as low-entropy sources for a multitude of quantum-science applications, ranging from quantum simulation and quantum many-body physics to proof-of-principle experiments in quantum metrology and quantum computing. For stability reasons, in the majority of cases the energetically lowest-lying atomic spin state is used. Here, we report the Bose-Einstein condensation of caesium atoms in the Zeeman-excited m = 2 state, realizing a non-ground-state Bose-Einstein condensate with tunable interactions and tunable loss.

Anomalous cooling of bosons by dimensional reduction.

Cold atomic gases provide a remarkable testbed to study the physics of interacting many-body quantum systems. Temperatures are necessarily nonzero, but cooling to the ultralow temperatures needed for quantum simulation purposes or even simply measuring the temperatures directly on the system can prove to be very challenging tasks. Here, we implement thermometry on strongly interacting two- and one-dimensional Bose gases with high sensitivity in the nanokelvin temperature range.

Observation of Confinement-Induced Resonances in a 3D Lattice.

We report on the observation of confinement-induced resonances for strong three-dimensional (3D) confinement in a lattice potential. Starting from a Mott-insulator state with predominantly single-site occupancy, we detect loss and heating features at specific values for the confinement length and the 3D scattering length. Two independent models, based on the coupling between the center-of-mass and the relative motion of the particles as mediated by the lattice, predict the resonance positions to a good approximation, suggesting a universal behavior.

Structural Investigations on Novel Non-Nucleoside Inhibitors of Human Norovirus Polymerase.

Human norovirus is the first cause of foodborne disease worldwide, leading to extensive outbreaks of acute gastroenteritis, and causing around 200,000 children to die annually in developing countries. No specific vaccines or antiviral agents are currently available, with therapeutic options limited to supportive care to prevent dehydration. The infection can become severe and lead to life-threatening complications in young children, the elderly and immunocompromised individuals, leading to a clear need for antiviral agents, to be used as treatments and as prophylactic measures in case of outbreaks.